Personalis Inc (STU:04X) Stock News, Headlines & Updates
Personalis Inc Stock News from GuruFocus
- 1
Jul 22, 2025
Personalis to Announce Second Quarter 2025 Financial Results
Business Wire • 4:00pm
Jul 18, 2025
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | PSNL Stock News
GuruFocus News • 3:01pm
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire • 3:01pm
Jul 10, 2025
Personalis (PSNL) Expands Partnership with Tempus AI for Cancer Detection
GuruFocus News • 9:00am
Jul 09, 2025
Personalis Expands Tempus Strategic Collaboration to Bring Ultra-Sensitive Cancer Recurrence Testing to Colorectal Cancer Patients
Business Wire • 4:00pm
Personalis Expands Tempus Strategic Collaboration to Bring Ultra-Sensitive Cancer Recurrence Testing to Colorectal Cancer Patients | PSNL Stock News
GuruFocus News • 3:20pm
Jun 03, 2025
Personalis' NeXT Personal® Predicts Cervical Cancer Recurrence Risk in New CALLA Phase 3 Study Analysis Presented at ASCO
Business Wire • 4:00pm
Personalis (PSNL) Blood Test Shows Promise in Detecting Cervical Cancer Early | PSNL Stock News
GuruFocus News • 3:15pm
Jun 02, 2025
New Data Shows NeXT Personal® Identifies Breast Cancer Patients Receiving Neoadjuvant Therapy that are at High Risk for Relapse
Business Wire • 4:00pm
Personalis (PSNL) Showcases Promising Results for NeXT Personal in Breast Cancer Care | PSNL Stock News
GuruFocus News • 3:46pm
New Data Shows NeXT Personal® Identifies Breast Cancer Patients Receiving Neoadjuvant Therapy that are at High Risk for Relapse | PSNL Stock News
GuruFocus News • 3:19pm
May 22, 2025
Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Assay for Residual Cancer and Recurrence Detection
Business Wire • 6:00am
Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Assay for Residual Cancer and Recurrence Detection | PSNL Stock News
GuruFocus News • 5:16am
May 19, 2025
PSNL to Discuss Future Plans in Upcoming Virtual Meeting | PSNL Stock News
GuruFocus News • 1:15pm
May 15, 2025
Guggenheim Initiates Buy Rating for Personalis (PSNL) with $6 Target | PSNL Stock News
GuruFocus News • 8:30am
Guggenheim Starts Coverage on Personalis (PSNL) with Buy Rating | PSNL Stock News
GuruFocus News • 5:46am
May 14, 2025
Personalis to Participate at the Craig-Hallum 22nd Annual Investor Conference
Business Wire • 4:00pm
May 07, 2025
Personalis (PSNL) Receives Price Target Boost from Analyst | PSNL Stock News
GuruFocus News • 7:03am
H.C. Wainwright Increases Price Target for Personalis (PSNL) to $9 | PSNL Stock News
GuruFocus News • 5:46am
Personalis Inc (PSNL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Reimbursement Challenges
GuruFocus News • 1:23am
Q1 2025 Personalis Inc Earnings Call Transcript
GuruFocus News • 11:09pm
Personalis (PSNL) Q1 2025 Earnings Reflects Strong Growth in Molecular Tests
GuruFocus News • 8:55pm
May 06, 2025
Personalis Reports First Quarter 2025 Financial Results
Business Wire • 4:00pm
Personalis Inc (PSNL) Q1 2025 Earnings: EPS of -$0.24 Beats Estimate, Revenue at $13.6M Misses Estimate
GuruFocus News • 3:41pm
PSNL Projects Diverse Revenue Streams Across Multiple Segments | PSNL Stock News
GuruFocus News • 3:16pm
Personalis (PSNL) Reports Strong Q1 Revenue and Testing Growth | PSNL Stock News
GuruFocus News • 3:16pm
May 05, 2025
Personalis Inc (PSNL) Q1 2025 Earnings Report Preview: What To Expect
GuruFocus News • 8:12am
Apr 28, 2025
Personalis' NeXT Personal® Detects 100% of Colorectal Cancer Relapses Ahead of Imaging in VICTORI Cancer Study
Business Wire • 5:00pm
Personalis' NeXT Personal® Detects 100% of Colorectal Cancer Relapses Ahead of Imaging in VICTORI Cancer Study | PSNL Stock News
GuruFocus News • 4:18pm
Personalis (PSNL) Reveals Promising Interim Results in Colorectal Cancer Detection | PSNL Stock News
GuruFocus News • 4:16pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news